Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Monday, Pluristem Therapeutics' Director, Israel Ben-yoram, made a $50,000 purchase of PSTI, buying 71,429 shares at a cost of $0.70 each. Bargain hunters are able to buy PSTI even cheaper than Ben-yoram did, with the stock changing hands as low as $0.58 at last check today — that's 17.1% below Ben-yoram's purchase price. Pluristem Therapeutics is trading up about 0.6% on the day Tuesday. This buy marks the first one filed by Ben-yoram in the past year.
And at Terex, there was insider buying on Friday, by Senior Vice President, CFO John D. Sheehan who purchased 572 shares for a cost of $33.44 each, for a trade totaling $19,128. Before this latest buy, Sheehan purchased TEX at 12 other times during the past twelve months, for a total cost of $165,294 at an average of $35.82 per share. Terex is trading off about 2.1% on the day Tuesday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.